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Aim: A causative relationship between acute coronary syndrome (ACS) and periodontitis has 
yet to be defined. The aim of this study was to assess if there are differences in levels of 
serum cytokines between individuals with or without ACS or periodontal comorbidity.  
Material and Methods: In a case-control study, individuals with ACS (78 individuals, 10.3% 
females) and matching healthy controls (78 individuals, 28.2% females) were included. 
Medical and dental examinations were performed to diagnose ACS and periodontitis. Serum 
levels of cytokines were assessed using Luminex technology.  
Results: A diagnosis of periodontitis in the ACS and control group was diagnosed in 52.6% 
and 12.8% of the individuals, respectively. The unadjusted odds-ratio that individuals with 
ACS also had periodontitis was 7.5 (95% CI: 3.4, 16.8, p0.001). Independent of periodontal 
conditions, individuals with ACS had significantly higher serum levels of IL8 (mean: 44.3 
and 40.0 pg/ml) and vascular endothelial growth factor (VEGF) (mean: 82.3 and 55.3 pg/ml) 
than control individuals. A diagnosis of periodontitis made no difference in serum cytokine 
expressions.  
Conclusion: The major contributor to serum cytokine expression was associated with a 
diagnosis of ACS. Elevated serum levels of VEGF were associated with ACS. Serum 
cytokine expression in individuals with ACS is unrelated to periodontal conditions.  
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Clinical Relevance 
Scientific rationale: ACS impacts coronary blood flow, causing conditions ranging from 
unstable angina, through to life-threatening myocardial infarctions. Limited information is 
available regarding the relationships between cytokine expression in individuals with acute 
coronary syndrome and periodontitis. 
Principal findings:  Independent of periodontal conditions, individuals with ACS had 
significantly higher serum levels of IL8 and VEGF than control individuals. 
Practical implications: Although Practical prediction strategies for those at greatest risk of 
ACS must be founded in a greater understanding of the link between circulatory and the more 
easily accessible inflammatory processes, such as that which sustained periodontitisa 
diagnosis of periodontitis has been associated with ACS, the inflammatory burden of 
periodontitis as expressed by a panel of pro-inflammatory cytokines in serum is not possible 
to identify at the time of the acute phase of coronary heart disease. This suggests that 







Acute coronary syndrome (ACS), has an enormous impact on mortality and morbidity 
worldwide (Timmis 2015). This term includes a range of conditions which precipitate the 
occlusion of coronary arterial blood flow, such as unstable angina through to fatal myocardial 
infarctions (Kaul et al. 2013). Periodontitis is a relatively common condition in adults and 
children which can lead to significant oral pathology (Eke et al. 2015). (Keyes and Rams 
2015).  Whilst many observational studies support a relationship between ACS and 
periodontitis, causation has yet to be defined (Lockhart et al. 2012). However, individuals 
with advanced periodontitis exhibit endothelial dysfunction along with evidence of systemic 
inflammation, which promotes their risk of developing cardiovascular disease (Amar et al. 
2003, Holtfreter et al. 2013). Whilst studies have demonstrated that periodontal treatment 
improves brachial artery endothelial function (Elter et al. 2006, Seinost et al. 2005, Tonetti et 
al. 2007), treatment of periodontitis did not impact the incidence of cardiovascular 
complications (Offenbacher et al. 2009, Beck et al. 2008). In addition, survival statistics from 
a six-year longitudinal study also failed to show that a diagnosis of periodontitis predicted 
mortality in older individuals (Renvert et al. 2015). Furthermore,  a systematic review of 
clinical trials  concluded that there was insufficient evidence to support the notion that  
periodontal therapy can prevent the recurrence of cardiovascular disease in patients with 
periodontitis (Li et al. 2014). There is a need to explore the systemic impact of periodontitis in 
terms of inflammatory markers, which may cast light on whether periodontal inflammation 
actively contributes to cardiovascular complications. 
 
Serum high sensitivity C-reactive protein (hs-CRP) has been identified as an important 
marker of systemic inflammation and those with elevated levels of serum CRP are at 
increased risk of mortality and morbidity from cardiovascular diseases (Ridker 2007). 
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Periodontitis is also associated with increased levels of CRP, and interleukin (IL)-18 (Buhlin 
et al. 2009). Some pro-inflammatory cytokines have been studied to explore the systemic 
inflammatory impact of periodontitis, leading to conflicting results. Elevated serum levels of 
IL6 and tumour necrosis factor alpha (TNF-) have been demonstrated in individuals with 
periodontitis in comparison with healthy individuals (Tang et al. 2011). In contrast, a report 
determined TNF- levels to be significantly lower in individuals with periodontitis than 
control individuals (Nakajima et al. 2010). Yet another study assessed  serum TNF- levels in 
individuals with or without periodontitis and failed to demonstrate a relationship between 
serum TNF- levels and periodontal status (Gokul et al. 2012). Thus, the relationship between 
periodontitis and system expression of TNF-α is unclear.  
 
With regard to other potential markers which may link periodontitis with systemic conditions,  
patients with diffuse coronary artery ectasiae have been shown to have elevated blood levels 
of VEGF (Savino et al. 2006). In ACS, elevated VEGF concentrations may serve as a 
surrogate marker of myocardial injury (Konopka et al. 2013) and indeed, serum VEGF levels  
increase with periodontitis severity (Pradeep et al. 2011). Hence, in patients at risk for ACS, 
there appears to be an important interplay between various growth factors and cytokines, 
which are associated with inflammatory status and platelet hyper-reactivity (Gori et al. 2009).  
 
Although many epidemiological studies have reported on potential casual associations 
between oral infections and cardio-metabolic diseases it remains unclear how oral infection 
may have an impact on cardiovascular diseases (Janket et al. 2015).  Thus, there appears to be 
no studies that have performed comprehensive analysis of serum cytokine levels in 
individuals with heart disease and periodontitis in comparison to cytokine levels in 
individuals without heart disease or other systemic diseases. The objectives of the present 
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study were to assess if there are differences in the levels of serum cytokine biomarkers 
between individuals who have ACS with or without periodontal comorbidity. The null-
hypothesis is that there are no differences in serum cytokine expressions between individuals 
with or without periodontitis and/or ACS pathology. 
 
Material and Methods 
In compliance with the Declaration of Helsinki, the Regional Ethics Committee in Lund, 
Sweden, approved the study (Institutional Review Board approval no. LU556-00). After the 
details of the original study protocol had been presented (Persson et al. 2003, Renvert et al. 
2010, Renvert et al. 2006) informed consent was obtained from the individuals. Briefly, 
consecutively surviving individuals admitted to the Kristianstad Central Hospital were 
enrolled if they had a diagnosis of ACS defined by chest pain associated with typical 
electrocardiogram (ECG) changes. The initial ECG was considered diagnostic for myocardial 
infarction if there was ST segment elevation of 2 mm or more in a chest lead, or ST segment 
elevation of 1 mm or more in a limb lead. ST depression and/or T-wave inversion changes 
combined with typical serial pattern of cardiac markers [i.e. creatinine kinase isoenzyme 
(CKMB) and troponin T (TnT)] according to local laboratory standards, were also considered 
diagnostic for myocardial infarction. Left bundle block (LBB) was considered diagnostic for 
myocardial infarction if chest pain combined with typical serial pattern of cardiac markers 
were present. At the time of admission, a blood sample was taken for further analysis of 
biomarkers of inflammation.  
 
Approximately one month after treatment and release from hospital, all surviving  these 
individuals with a diagnosis of ACS received a comprehensive periodontal examination. The 
periodontal examination included routine measurements of probing pocket depths, extent of 
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gingival inflammation and radiographic analysis of alveolar bone loss. The methods used to 
diagnose gingivitis and bone loss have been described in detail (Persson et al. 2003). In the 
present study, individuals with loss of alveolar bone, verified by a distance between cement 
enamel junction and the highest coronal bone level exceeding 4 mm, at ≥30 % of teeth, 
combined with bleeding on probing (BOP) ≥20 % and a probing pocket depth ≥5 mm at four 
teeth or more were considered as having periodontitis.  All study individuals were examined 
by one and the same examiner (Susanna Persson-Sättlin, dental hygienist) (Renvert et al. 
2004) . This examiner was kept unaware of the medical diagnosis by not having access to 
medical data. Study individuals were instructed not to provide any pertinent information in 
regards to cardiovascular events 
 
Individuals matched by age, socio-economic status, and smoking habits without a preceding 
diagnosis of ACS, or a diagnosis of ACS within 3 years after the enrolment in the present 
study, were included (Persson et al. 2003, Renvert et al. 2010). The control individuals were 
identified among friends to those with a current ACS or from registry available to the 
investigators. Data based on analysis of 80 patients with ACS and 80 control individuals from 
a group consisting of friends of the patients (39 individuals) with ACS, and from a research 
registry of subjects (41 individuals) who had participated in a timely health survey (Back et 
al. 1999). The 41 individuals identified from the health survey were selected based on a best 
fit principle (age, gender, smoking status, socio-economics) in comparison to the individuals 
in the test group.  
 
The control individuals also received a comprehensive cardiological medical examination at 
Kristianstad Central Hospital including an ECG and were cleared from evidence of ACS. 
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Following the medical examination, the control individuals also received a comprehensive 
dental examination consistent with the examinations that the individuals with ACS received.  




Analysis of selected cytokines 
A broad panel including 23 pro- and anti-inflammatory cytokines was assessed using 
Luminex MagPix multi analyte technology (Luminex, Austin TX. USA).  This panel included 
the following cytokines; Basic FGF , Eotaxin, GCSF (granulocyte colony-stimulating factor), 
IFN interferon gamma), Interleukin (IL): IL1β (interleukin 1 beta), IL1ra (receptor 
antagonist), IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12p70(active heterodimer),  IL13, IL17A, 
IP10 (interferon-inducible protein-10), MCP1 (monocyte chemo-attractant protein-1), MIP1a 
(macrophage inflammatory protein 1alpha ), MIP1b (macrophage inflammatory protein 
1beta), PDGFBB (platelet-derived growth factor subunit B), TNFα (tumor necrosis factor 
alpha), and VEGF (Vascular endothelial growth factor).The cytokine kit was purchased from 
Bio-Rad (Sundbyberg, Sweden) and the cytokines were detected following the manufacturer’s 
instructions. The researcher who performed the cytokine analysis was unaware of where the 
samples represented individuals with periodontitis or not, or any other clinical data. Briefly, 
samples were defrosted, incubated with antibodies, immobilized on color-coded magnetic 
beads, washed to remove unbound material, and then incubated with biotinylated antibodies. 
After further washing, a streptavidin-phycoerythrin conjugate, which binds to the biotinylated 
antibodies, was added before a final washing step. The Luminex analyser determined the 
magnitude of the phycoerythrin-derived signal. Duplicate readings were performed in a subset 
of samples demonstrating a high level of agreement between measurements with intra-class 
Formatted: Font: Italic
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correlation (ICC) varied between 0.95 and 1.0 (p<0.001). Serum for the analysis of cytokines 
were not available for all individuals, Therefore, 76 individuals in the test and control groups 




The statistical package SPSS 22 for Windows was used for all analyses. Multivariate analysis 
with Bonferroni correction adjusted for gender was used to determine whether significant 
differences in cytokine levels existed between study groups. Chi-square analysis was used for 
dichotomized data. Independent t-tests (equal variance not assumed) were used for numerical 
data.  Unadjusted Mantel-Haenszel common odds ratio was calculated. Due to the absence of 
data on serum cytokine levels from study individuals with or without heart disease and 
periodontitis were not available at the time of study design a sample size calculation was not 
possible to perform prior to the study.   In previous reports on this study materiel in regards to 
gender, smoking status, and age we have failed to identify that these factors were confounders 




Data from 156 adult individuals including 76 individuals with a diagnosis of ACS (10.3 % 
females), and from 76 control individuals without clinical evidence of cardiovascular disease 
were included (28.2 % females). The mean age of individuals in the ACS and control groups 
was 59.7 years (S.D. 9.2) and 59.7 years (S.D. 9.1), respectively. Serum lipid values, white 
blood cell counts, HbA1c levels were within the reference range for normal conditions. 
Characteristic medical values are presented in Table 1. 
Formatted: Font color: Black
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In the ACS group as well as in the control group statistical analysis failed to demonstrate that 
the prevalence of periodontitis differed by gender. Statistical analysis failed to demonstrate a 
difference in the frequency of ACS by age (p=0.96), smoking (p=0.60) or number of 
remaining teeth (p=0.29). In the ACS and control groups 22.7 % and 19.2 % were smokers, 
respectively. A diagnosis of periodontitis in the ACS and control group was diagnosed in 52.6 
% and 12.8 % of the individuals, respectively. The unadjusted Mantel-Haenszel common 
odds-ratio that individuals with ACS also had periodontitis was 7.5 (95 CI: 3.4, 16.8, 
p0.001). The prevalence of gingivitis (bleeding on probing ≥20 % of sites, 4 per tooth) did 
not differ by cardiovascular status. In fact, 100 % of the individuals with ACS and 97.3 % of 
the control individuals presented with gingivitis. Evidence of alveolar bone loss (≥4 mm at 
≥30 % of teeth) was 73.1 % in the ACS group and 23.1 % in the control group (p<0.001). 
 
In the control group (individuals without a diagnosis of ACS) statistical analysis failed to 
demonstrate differences in hs-CRP levels (p=0.95) (Figure 1) between those with or without a 
diagnosis of periodontitis. In individuals with a diagnosis of ACS statistical analysis also did 
not demonstrate differences in hs-CRP levels (p=0.41) between those with or without a 
diagnosis of periodontitis. Serum hs-CRP values were significantly higher in individuals with 
a diagnosis of ACS in comparison to those individuals without a diagnosis of ACS (p<0.001). 
Multivariate analysis adjusting for gender failed to demonstrate differences in serum cytokine 
levels in both ACS and control groups. 
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Independent t-test (equal variance not assumed) of cytokines in serum between individuals 
with or without a diagnosis of ACS and periodontitis (Tables 2 and 3) 
Mean values and standard deviations for 23 cytokines studied in individuals with or without 
ACS are presented. Independent of periodontal conditions, individuals with ACS had 
significantly higher serum levels of IL8 (mean value: 44.3 and 40.0, respectively, mean diff: 
4.3, SE. diff: 1.6, 95 % CI: 1.2, 7.5, p<0.01), and VEGF (mean value: 82.3 and 55.3, 
respectively, mean diff: 27.0, SE. diff: 9.4, 95 % CI: 8.4, 45.4, p<0.01) than control 
individuals. Statistical analysis identified that in individuals with ACS, a diagnosis of 
periodontitis or not made no difference in serum cytokine expression. Individuals with ACS 
without periodontitis had higher serum levels of VEGF than control individuals without 
periodontitis (mean value: 90.0 and 55.1, respectively, mean diff: 34.9, SE. diff: 12.8, 95 % 
CI: 9.3, 60.4, p<0.01). With increase in severity of disease from periodontal and 
cardiovascular health to having both periodontitis and ACS serum VEGF levels increased 





The present study identified a high odds ratio that individuals with ACS also had 
periodontitis. This finding is consistent with several other studies.  The present study also 
demonstrated that a subset of pro-inflammatory cytokines were found at high levels in 
individuals without a diagnosis of periodontitis but with ACS. This suggests that periodontitis 
may not to any greater extent contribute to the inflammatory burden of a person at risk for or 
having ACS. The impact of the current ACS status may overshadow the inflammatory impact 
of periodontitis. A recent meta-analysis has demonstrated scientific evidence that periodontal 
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therapies may improve improve endothelial function and reduce biomarkers (i.e. hs-CRP, 
TNF-  and IL6) of atherosclerotic disease, especially in those already suffering from heart 
disease and/or diabetes (Teeuw et al. 2014). 
The present study failed to demonstrate that a diagnosis of periodontitis enhanced the 
expression of serum cytokine levels in individuals with ACS. We did show that elevated 
levels of IL8 and VEGF were associated with a diagnosis of ACS. Consistent with other 
studies, however, serum hs-CRP levels were significantly higher in individuals with ACS and 
periodontitis than in healthy control individuals (no clinical evidence of ACS or 
periodontitis). Gingival bleeding and probing pocket depth did not impact serum hs-CRP or 
serum cytokine levels. Consistently, the present study also failed to demonstrate a difference 
in serum hs-CRP levels in individuals with or without periodontitis and in the absence of a 
diagnosis of ACS. This is in broad agreement with the current literature in this area (Baser et 
al. 2014, Renvert et al. 2013). The identified lack of impact on serum cytokine levels when 
gingival bleeding was included may be explained by the high prevalence of gingival 
inflammation in all study individuals. The decision to use serum samples to assess the 
presence of pro and anti-inflammatory cytokines was based on the concept that systemic 
hyper-inflammation may, in part be related to the pathology of periodontitis. To the best of 
our knowledge there are limited data on the impact of periodontitis on the levels of a broader 
panel of cytokines in serum from individuals with or without ACS.  
 
VEGF is a cytokine that is known to be involved in angiogenesis. It has been shown that 
VEGF levels in myocardial infarction may reflect the progressive stages of angiogenesis 
activity in the ischemic-necrotic myocardium (Lee et al. 2004). Levels of VEGF in serum 
correlate with clinical parameters of periodontal disease and serum VEGF levels increase 
progressively with the severity of periodontitis (Pradeep et al. 2011), contributing to its   
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pathogenesis (Artese et al. 2010, Prapulla et al. 2007). Our findings are consistent with these 
observations. Studies of gingival biopsies at different stages of inflammation have shown that 
levels of VEGF are related to endothelial proliferation in gingival tissues collected from 
individuals with chronic periodontitis (Kasprzak et al. 2012). Elevated VEGF levels in 
individuals with chronic periodontitis are linked with VEGF and β-defensin-1 gene 
polymorphisms (Tian et al. 2013). The present study identified that serum concentrations of 
VEGF were associated with ACS but not to periodontitis. Data have shown that in ACS 
serum VEGF concentrations are elevated and can serve as a surrogate marker of myocardial 
injury (Konopka et al. 2013). Data have also suggested that VEGF induces IP10 expression, 
which is a pro-inflammatory marker which is associated with the developing and chronic 
pathology of ACS process (Boulday et al. 2006, Frangogiannis 2004, Wilsgaard et al. 2015). 
 
Chronic periodontitis presents with phases of disease activity and quiescence. Although the 
routine criteria (extent of bone loss, pocket depth  5 mm, gingival bleeding  30 %) are well 
established, such criteria cannot identify active periodontitis. Most likely, analysis of serum or 
gingival crevicular fluid levels of pro- and anti-inflammatory cytokines may distinguish 
between chronic and acute periodontitis. There is a need to further explore serum cytokine 
threshold levels that indicate periodontal inflammation. It is possible that additional studies of 
the infectious bacterial aetiology in periodontitis in relation to clinical and cytokine data can 
cast light on periodontal disease activity and its impact on cardiovascular disease. Whilst the 
present report revealed that elevated cytokine levels were associated with periodontitis and 
coronary disease, it is recognised that there are practical limitations on the interpretation of 
the expression of pro- and anti-inflammatory cytokines, in terms of time- and event 
dependency, which make their clinical predictivities potentially problematic.   
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One limitation of the present study is that the subgroup analyses included relatively few cases.  
The present study is based on a cohort of individuals who either were admitted to emergency 
care with a diagnosis of ACS, or who belonged to a sample of the community without a 
confirmed diagnosis of heart disease. Nevertheless, the study design represents case selection 
based on consecutive cases with ACS and is therefore not likely to be influenced by 
periodontal status. In addition, the individuals that had received treatment for ACS had most 
likely been prescribed medications which could have impacted periodontal status during the 
time of dental examination. Logistically, it was not possible to perform the dental 
examination at the time of admittance to the hospital for ACS. The investigators have no 
information about past diagnosis and treatment of periodontitis, on the progression of 
periodontitis, or if these study individuals with or without periodontitis were in a current or 
recent phase of active periodontitis or not and that could have had an impact on pro-
inflammatory cytokine levels. Information on Body Mass Index (BMI) was not collected. 
Therefore, no adjustment for this factor could be made. Data analysis on the impact of age, 
gender, and smoking status in previous reports (Persson et al. 2003, Renvert et al. 2004) have 
failed to identify that these factors were confounders to the outcome. The explanations to this 
can be explained by the study design to match individuals in test and control groups, and to 
the fact that few individuals were smokers, and that the the age range was narrow.  
 
In spite of the fact that few individuals were smokers, all individuals had poor oral hygiene 
reflected by the presence of gingival inflammation approaching 100 %. Thus, the periodontal 
diagnosis, including data on gingival inflammation, pocket depths, and bone loss was 
predominantly defined by data based on alveolar bone loss evaluations. The analysis of serum 
from the individuals with ACS was performed on blood samples collected at the time of 
admission and before any medical intervention or medication. Thus, the cytokine levels in 
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serum represent a ‘snapshot’ of cytokine expression at that particular time point of admission. 
Likewise, the blood samples from the control individuals were collected from individuals who 
were not taking medication or had had their medication changed within the preceding three 
months. 
 
In conclusion, a diagnosis of ACS had a major impact on serum cytokine expression and 
elevated serum levels of VEGF were also associated with ACS. However, we found serum 
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Figure Legends 
Figure 1. Box-plot diagram illustrating differences in hs-CRP levels by cardiovascular and 
periodontal status ( = outlier). 
Figure 2. Box-plot diagram illustrating differences in VEGF levels by cardiovascular and 
periodontal status ( = outlier). 
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Tables 
Table 1. Mean levels and standard deviations of medical values in control and ACS 
individuals.  
Variables Control (n=78) ACS (n=78) Sign 
Mean S.D. Mean S.D. 
Cholesterol (mmol/l) 5.6 0.9 5.0 1.2 p=0.001 
Triglycerides (mmol/l) 1.8 1.7 1.6 0.8 NS 
High density lipids (mmol/l) 1.4 0.4 1.2 0.3 p=0.000 
Low density lipids (mmol/l) 3.4 0.9 3.0 1.2 p<0.05 
HbA1c (mmol/mol) 28.3 13.7 31.7 12.8 NS 
WBC (×109/l) 6.4 1.8 8.6 2.9 p=0.000 
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Table 2. Mean levels and standard deviations of serum cytokines in control individuals and 
individuals with a diagnosis of ACS. (* = significant differences between groups, p<0.01) 
Cytokine Control (n=78) ACS (n=78) 
Mean S.D. Mean S.D. 
BasicFGF 75.6 54.1 87.1 68.6 
Eotaxin 127.2 167.3 110.1 65.5 
GCSF 124.6 65.5 137.0 55.0 
IFN 95.8 138.7 104.9 114.0 
IL1β 5.8 8.2 5.3 3.3 
IL1ra 592.4 2088.8 308.4 537.9 
IL4 4.5 2.1 4.9 1.9 
IL5 10.9 4.8 11.8 3.6 
IL6 20.4 54.6 16.1 11.4 
IL7 17.5 13.5 16.1 4.8 
IL8* 40.0 9.3 44.3 10.3 
IL9 28.7 72.1 23.3 17.1 
IL10 36.2 121.3 29.3 60.8 
IL12p70 71.7 118.5 74.2 63.4 
IL13 9.5 11.5 8.6 3.5 
IL17A 132.9 93.8 163.8 133.7 
IP10 707.9 495.4 824.7 749.0 
MCP1 60.8 41.0 65.9 35.1 
MIP1a 11.6 6.1 12.2 8.8 
MIP1b 156.6 57.9 171.7 56.1 
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PDGFBB 3919.0 1344.7 4026.7 1358.8 
TNFα 85.3 185.5 72.1 66.1 
VEGF* 55.3 53.1 82.3 63.6 
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Table 3. Levels of cytokines in serum from control individuals without periodontitis (n=68) or 
with periodontitis (n=10) and individuals with a diagnosis of ACS without periodontitis 
(n=37) or with periodontitis (n=41). Data are presented for mean values, mean differences, 
S.E. mean diff, 95 % CI and significance when adjusted for smoking history.  
Cytokine Control ACS Mean diff S.E. diff 95 % CI Sign 
IL8 40.0 44.3 4.3 1.6 1.2, 7.5 p<0.01 
VEGF 55.3 82.3 27.0 9.4 8.4, 45.4 p<0.01 
       







S.E. diff 95 % CI Sign 
VEGF 55.1 90.0 34.9 12.8 9.3, 60.4 p<0.01 
       







S.E. diff 95 % CI Sign 
 
Data analysis failed to show differences by periodontal status in individuals with 
ACS. 
NS 
 
 
 
